• Study on Zolbetuximab and mFOLFOX6 for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Italy Poland Spain
  • Study of Amivantamab and Cetrelimab for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Italy Poland Spain
  • Study of Lurbinectedin and Pembrolizumab for Patients with Relapsed Small Cell Lung Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Spain
  • Study Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Italy Spain
  • Safety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Hungary Italy Poland Spain
  • Study on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Denmark France Greece Italy The Netherlands +1
  • Study on Hydrocortisone and Food Exposure Therapy for Patients with Binge Eating Disorder

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Italy The Netherlands Poland +1
  • Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark France Germany Hungary +6
  • Study on Treosulfan, Fludarabine Phosphate, and Thiotepa for Patients with Myelofibrosis Undergoing Haplo-identical Transplantation

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France

powered by